APA (7th ed.) Citation

Peng, P., Pan, Y., Lu, X., Xu, H., Zhou, Z., He, Y., . . . Zhou, L. (2023). Treatment of immune thrombocytopenia with hetrombopag olamine tablets in a Kabuki syndrome patient with new KMT2D mutations. Platelets, 34(1), 1. https://doi.org/10.1080/09537104.2023.2249562

Chicago Style (17th ed.) Citation

Peng, Peng, Ying Pan, Xueqing Lu, Hui Xu, Ziwei Zhou, Yuanqing He, Huiru Wang, Changcheng Zheng, and Li Zhou. "Treatment of Immune Thrombocytopenia with Hetrombopag Olamine Tablets in a Kabuki Syndrome Patient with New KMT2D Mutations." Platelets 34, no. 1 (2023): 1. https://doi.org/10.1080/09537104.2023.2249562.

MLA (9th ed.) Citation

Peng, Peng, et al. "Treatment of Immune Thrombocytopenia with Hetrombopag Olamine Tablets in a Kabuki Syndrome Patient with New KMT2D Mutations." Platelets, vol. 34, no. 1, 2023, p. 1, https://doi.org/10.1080/09537104.2023.2249562.